
Character Biosciences Expands Leadership Team and Announces Series B Extension
Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced the expansion of its leadership team with four senior appointments and an expansion of its Series B financing, bringing total capital raised in the round to…